Hypertensive patients (n=10305) with total cholesterol < 251 mg/dL were randomly assigned to atorvastatin 10 mg daily and a significant reduction in non-fatal MI, fatal CHD and stoke (fatal and non-fatal) was noticed. No significant difference was observed on all-cause mortality. The trial was stopped earlier than expected of 5 years because of beneficial treatment.
ASCOT-LLA
PETN
GUSTO-I
AEMT-CC
MoCA
ASHRAE
EBUS-NA
WOSCOPS